Literature DB >> 18694967

Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.

Christopher D Bayliss1, J Claire Hoe, Katherine Makepeace, Patricia Martin, Derek W Hood, E Richard Moxon.   

Abstract

Bacteria adapt to environmental changes through high-frequency switches in expression of specific phenotypes. Localized hypermutation mediated by simple sequence repeats is an important mechanism of such phase variation (PV) in Neisseria meningitidis. Loss or gain of nucleotides in a poly(C) tract located in the reading frame results in switches in expression of lgtG and determines whether a glucose or a phosphoethanolamine (PEtn) is added at a specific position in the inner core lipopolysaccharide (LPS). Monoclonal antibody (MAb) B5 is bactericidal for N. meningitidis strain 8047 when PEtn is present in the inner core LPS and lgtG is switched "off." Escape from the bactericidal activity of this antibody was examined by subjecting strain 8047 to multiple cycles of growth in the presence of MAb B5 and human serum. Escape variants with alterations in the lgtG repeat tract rapidly accumulated in bacterial populations during selection with this antibody. Strain 8047 was outcompeted in this assay by the 8047 Delta mutS strain due to the elevated PV rate of this mismatch repair mutant and hence the greater proportion of preexisting phase variants of lgtG in the inoculum. This mutS mutant was also more virulent than strain 8047 during escape from passive protection by MAb B5 in an in vivo infant rat model of bacteremia. These results provide an example of how PV rates can modulate the occurrence and severity of infection and have important implications for understanding the evolution of bacterial fitness in species subject to environmental variations that occur during persistence within and transmission between hosts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694967      PMCID: PMC2573340          DOI: 10.1128/IAI.00395-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

Authors:  Michael P Jennings; Yogitha N Srikhanta; E Richard Moxon; Marco Kramer; Jan T Poolman; Betsy Kuipers; Peter van der Ley
Journal:  Microbiology (Reading)       Date:  1999-11       Impact factor: 2.777

2.  Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Authors:  A Giraud; I Matic; O Tenaillon; A Clara; M Radman; M Fons; F Taddei
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

Review 3.  The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis.

Authors:  C D Bayliss; D Field; E R Moxon
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58.

Authors:  N J Saunders; A C Jeffries; J F Peden; D W Hood; H Tettelin; R Rappuoli; E R Moxon
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

5.  Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination.

Authors:  D A Ala'Aldeen; K R Neal; K Ait-Tahar; J S Nguyen-Van-Tam; A English; T J Falla; P M Hawkey; R C Slack
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  Mismatch repair and the regulation of phase variation in Neisseria meningitidis.

Authors:  A R Richardson; I Stojiljkovic
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

7.  Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.

Authors:  J S Plested; B L Ferry; P A Coull; K Makepeace; A K Lehmann; F G MacKinnon; H G Griffiths; M A Herbert; J C Richards; E R Moxon
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B.

Authors:  J S Plested; M A Gidney; P A Coull; H G Griffiths; M A Herbert; A G Bird; J C Richards; E R Moxon
Journal:  J Immunol Methods       Date:  2000-04-03       Impact factor: 2.303

9.  The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness.

Authors:  P Funchain; A Yeung; J L Stewart; R Lin; M M Slupska; J H Miller
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

10.  Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.

Authors:  Joyce S Plested; Shannon L Harris; J Claire Wright; Philip A Coull; Katherine Makepeace; Margaret-Anne J Gidney; Jean-Robert Brisson; James C Richards; Dan M Granoff; E Richard Moxon
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

View more
  24 in total

1.  Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort.

Authors:  Fadil A Bidmos; Keith R Neal; Neil J Oldfield; David P J Turner; Dlawer A A Ala'Aldeen; Christopher D Bayliss
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

2.  Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.

Authors:  Lisa A Lewis; David M Vu; Dan M Granoff; Sanjay Ram
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria.

Authors:  Laty A Cahoon; H Steven Seifert
Journal:  Mol Microbiol       Date:  2011-08-04       Impact factor: 3.501

4.  Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro.

Authors:  George F Santos; Marzia Giuliani; Laura Santini; Jeanette Adu-Bobie; Mariagrazia Pizza; Rino Rappuoli; William Wacknov; John Donnelly
Journal:  Clin Vaccine Immunol       Date:  2009-08-26

5.  Slipped-Strand Mispairing in the Gene Encoding Sialidase NanH3 in Gardnerella spp.

Authors:  Shakya P Kurukulasuriya; Mo H Patterson; Janet E Hill
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

6.  Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance.

Authors:  Hassan Safi; Pooja Gopal; Subramanya Lingaraju; Shuyi Ma; Carly Levine; Veronique Dartois; Michelle Yee; Liping Li; Landry Blanc; Hsin-Pin Ho Liang; Seema Husain; Mainul Hoque; Patricia Soteropoulos; Tige Rustad; David R Sherman; Thomas Dick; David Alland
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-05       Impact factor: 11.205

Review 7.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

Review 8.  Pilin gene variation in Neisseria gonorrhoeae: reassessing the old paradigms.

Authors:  Stuart A Hill; John K Davies
Journal:  FEMS Microbiol Rev       Date:  2009-05       Impact factor: 16.408

9.  Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation.

Authors:  Manish Sadarangani; Claire J Hoe; Katherine Makepeace; Peter van der Ley; Andrew J Pollard
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

10.  Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.

Authors:  Youssif Mohammed Ali; Azam Hayat; Bayad Mawlood Saeed; Kashif S Haleem; Saleh Alshamrani; Hany I Kenawy; Viviana P Ferreira; Gurpanna Saggu; Anna Buchberger; Peter J Lachmann; Robert B Sim; Dimitrios Goundis; Peter W Andrew; Nicholas J Lynch; Wilhelm J Schwaeble
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.